Trichostatin A improves the inflammatory response and liver injury in septic mice through the FoxO3a/autophagy signaling pathway

doi:10.5847/wjem.j.1920-8642.2022.056

Abstract

Abstract:

BACKGROUND: Sepsis-induced liver injury is a fatal complication of sepsis. Trichostatin A (TSA) regulates inflammation and autophagy in some human diseases, and forkhead box O3a (FoxO3a) has been shown to regulate autophagy. The present study aims to investigate whether TSA exerts its effects on septic liver injury through the FoxO3a/autophagy signaling pathway.

METHODS: A sepsis mouse model was constructed by the cecal ligation and puncture (CLP) method, and AML12 cells were pretreated with lipopolysaccharide (LPS) (1 μg/mL) to establish a sepsis cell model. Forty mice were divided into four groups, namely control group, TSA group, CLP group, and CLP+TSA group, with 10 mice in each group. Cells were divided into control group, TSA group, LPS group, and LPS+TSA group. Hematoxylin-eosin (H&E) staining and biochemical methods were used to evaluate liver tissue injury. Enzyme-linked immunosorbent assay (ELISA) was applied to detect the expression of proinflammatory cytokines, and Western blotting and immunofluorescence were used to measure autophagy-related protein expression.

RESULTS: Compared with the CLP group (mice), the proinflammatory cytokines (interleukin-β [IL-β] 2,665.27±324.90 pg/mL to 2,080.26±373.66 pg/mL; interleukin-6 [IL-6] 399.01±60.98 pg/mL to 221.90±46.89 pg/mL) and the hepatocyte injury markers (aspartate transaminase [AST] from 198.18±27.07 U/L to 128.42±20.55 U/L; alanine aminotransferase [ALT] from 634.98±74.10 U/L to 478.60±32.56 U/L) were notably decreased after TSA intervention. Moreover, LC3 II and FoxO3a showed an obvious increase and P62 showed an obvious decrease in the CLP+TSA group. Cell experiment results showed the similar trend. After FoxO3a gene was knocked down in AML12 cells, the promotion of autophagy and the improvement of liver enzyme index and inflammation by TSA were weakened.

CONCLUSION: TSA may improve the inflammatory response and liver injury in septic mice through FoxO3a/autophagy.

Key words: Sepsis, Liver injury, Trichostatin A, Autophagy, Inflammation

Mei-jia Shen, Li-chao Sun, Xiao-yu Liu, Meng-chen Xiong, Shan Li, A-ling Tang, Guo-qiang Zhang. Trichostatin A improves the inflammatory response and liver injury in septic mice through the FoxO3a/autophagy signaling pathway[J]. World Journal of Emergency Medicine, 2022, 13(3): 182-188.

Figures/Tables 5

Figure 1.

Table 1.

Figure 2.

Table 2.

Table 3.

References 26

1	Machado FR, Mazza BF. Improving mortality in sepsis: analysis of clinical trials. Shock. 2010; 34(Suppl 1):54-8. doi: 10.1097/SHK.0b013e3181e7e8b4
2	Mann EA, Baun MM, Meininger JC, Wade CE. Comparison of mortality associated with sepsis in the burn, trauma, and general intensive care unit patient: a systematic review of the literature. Shock. 2012; 37(1):4-16. doi: 10.1097/SHK.0b013e318237d6bf
3	Mizushima N, Ohsumi Y, Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct Funct. 2002; 27(6):421-9. doi: 10.1247/csf.27.421 pmid: 12576635
4	Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011; 469(7330):323-35. doi: 10.1038/nature09782
5	Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008; 132(1):27-42. doi: 10.1016/j.cell.2007.12.018 pmid: 18191218
6	Mizushima N, Levine B. Autophagy in mammalian development and differentiation. Nat Cell Biol. 2010; 12(9):823-30. doi: 10.1038/ncb0910-823 pmid: 20811354
7	Hsiao HW, Tsai KL, Wang LF, Chen YH, Chiang PC, Chuang SM, et al. The decline of autophagy contributes to proximal tubular dysfunction during sepsis. Shock. 2012; 37(3):289-96. doi: 10.1097/SHK.0b013e318240b52a
8	Shao L, Xiong X, Zhang Y, Miao H, Ren Y, Tang X, et al. IL-22 ameliorates LPS-induced acute liver injury by autophagy activation through ATF4-ATG7 signaling. Cell Death Dis. 2020; 11(11):970. doi: 10.1038/s41419-020-03176-4
9	Pei L, He L. Hepatoprotective effect of anemoside B4 against sepsis-induced acute liver injury through modulating the mTOR/p70S6K-mediated autophagy. Chem Biol Interact. 2021; 345:109534. doi: 10.1016/j.cbi.2021.109534
10	Yu Q, Zou L, Yuan X, Fang F, Xu F. Dexmedetomidine protects against septic liver injury by enhancing autophagy through activation of the AMPK/SIRT1 signaling pathway. Front Pharmacol. 2021; 12:658677. doi: 10.3389/fphar.2021.658677
11	Zhang JB, Ng S, Wang JG, Zhou J, Tan SH, Yang ND, et al. Histone deacetylase inhibitors induce autophagy through FoxO1-dependent pathways. Autophagy. 2015; 11(4):629-42. doi: 10.1080/15548627.2015.1023981
12	Kim SJ, Park JS, Lee DW, Lee SM. Trichostatin A protects liver against septic injury through inhibiting toll-like receptor signaling. Biomol Ther (Seoul). 2016; 24(4):387-94. doi: 10.4062/biomolther.2015.176
13	Cui SN, Chen ZY, Yang XB, Chen L, Yang YY, Pan SW, et al. Trichostatin A modulates the macrophage phenotype by enhancing autophagy to reduce inflammation during polymicrobial sepsis. Int Immunopharmacol. 2019; 77:105973. doi: 10.1016/j.intimp.2019.105973
14	Guo Y, Li Z, Shi C, Li J, Yao M, Chen X. Trichostatin A attenuates oxidative stress-mediated myocardial injury through the FoxO3a signaling pathway. Int J Mol Med. 2017; 40(4):999-1008. doi: 10.3892/ijmm.2017.3101
15	Liu YM, Lv J, Zeng QL, Shen S, Xing JY, Zhang YY, et al. AMPK activation ameliorates D-GalN/LPS-induced acute liver failure by upregulating FoxO3a to induce autophagy. Exp Cell Res. 2017; 358(2):335-42. doi: 10.1016/j.yexcr.2017.07.008
16	Funk DJ, Parrillo JE, Kumar A. Sepsis and septic shock: a history. Crit Care Clin. 2009; 25(1):83-101, viii. doi: 10.1016/j.ccc.2008.12.003
17	Deitch EA. Rodent models of intra-abdominal infection. Shock. 2005; 24(Suppl 1):19-23. doi: 10.1097/01.shk.0000191386.18818.0a
18	Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006; 25(51):6680-4. doi: 10.1038/sj.onc.1209954 pmid: 17072321
19	Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010; 140(6):805-20. doi: 10.1016/j.cell.2010.01.022 pmid: 20303872
20	Takano KI, Yamamoto S, Tomita K, Takashina M, Yokoo H, Matsuda N, et al. Successful treatment of acute lung injury with pitavastatin in septic mice: potential role of glucocorticoid receptor expression in alveolar macrophages. J Pharmacol Exp Ther. 2011; 336(2):381-90. doi: 10.1124/jpet.110.171462
21	Oh JE, Lee HK. Pattern recognition receptors and autophagy. Front Immunol. 2014; 5:300.
22	Brealey D, Singer M. Mitochondrial dysfunction in Sepsis. Curr Infect Dis Rep. 2003; 5(5):365-71. doi: 10.1007/s11908-003-0015-9 pmid: 13678565
23	Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA, et al. Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol. 2012; 13(3):255-63. doi: 10.1038/ni.2215
24	Guo Y, Li Z, Shi C, Li J, Yao M, Chen X. Trichostatin A attenuates oxidative stress-mediated myocardial injury through the FoxO3a signaling pathway. Int J Mol Med. 2017; 40(4):999-1008. doi: 10.3892/ijmm.2017.3101
25	Ali T, Rahman SU, Hao Q, Li W, Liu Z, Ali Shah F, et al. Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FoxO3a regulation. J Pineal Res. 2020; 69(2):e12667.
26	Wu Y, Leng Y, Meng Q, Xue R, Zhao B, Zhan L, et al. Suppression of excessive histone deacetylases activity in diabetic hearts attenuates myocardial ischemia/reperfusion injury via mitochondria apoptosis pathway. J Diabetes Res. 2017; 2017: 8208065.

Parameters	Control group	TSA group	CLP group	CLP+TSA group
ALT ^a, U/L	54.92±9.68	34.36±12.90	198.18±27.07^**	128.42±20.55^#
AST ^a, U/L	206.05±17.11	100.49±6.39^**	634.98±74.10^**	478.60±32.56^#
IL-6 ^a, pg/mL	371.62±27.69	306.04±13.05^**	2,665.27±324.90^**	2,080.26±373.66^#
TNF-α ^a, pg/mL	177.79±24.72	135.00±17.40^*	399.01±60.98^**	221.90±46.89^##
LC3 II ^b	1	1.46±0.02^**	1.36±0.01^**	1.66±0.04^##
P62 ^b	1	0.60±0.02^**	0.87±0.02^**	0.59±0.02^##
FoxO3a ^b	1	2.03±0.13^**	1.49±0.02^**	2.89±0.03^##

Parameters	Control group	TSA group	LPS group	LPS+TSA group
ALT ^a, U/L	5.05±0.55	14.20±2.20	29.42±0.62^**	23.47±0.64^##
AST ^a, U/L	9.55±0.65	18.90±3.10	63.52±4.50^**	38.51±1.50^##
LC3 II ^b	1	1.77±0.02^**	1.39±0.01^**	1.87±0.01^##
P62 ^b	1	0.50±0.01^**	0.73±0.01^**	0.38±0.01^##
Foxo3a ^b	1	2.23±0.02^**	1.79±0.01^**	3.10±0.07^##

Parameters	Control group	si-negative control			si-FoxO3a
Parameters	Control group	TSA group	LPS group	LPS+TSA group	TSA group	LPS group	LPS+TSA group
ALT ^a, U/L	5.37±0.63	14.13±1.80	29.27±0.52	23.33±0.50	14.63±1.03	38.57±2.30^**	29.20±1.10^**
AST ^a, U/L	9.07±0.87	20.27±3.18	57.00±1.59	39.57±1.94	19.63±3.03	71.23±5.85^*	46.70±2.90^*
IL-6 ^a, pg/mL	40.05±1.96	111.77±2.53	500.50±7.96	355.07±9.71	132.07±2.76^**	598.57±14.01^**	413.73±26.24^*
TNF-α ^a, pg/mL	10.33±1.25	11.93±1.69	54.15±2.79	36.77±2.39	13.47±1.92^*	66.47±3.03^*	50.43±3.35^**
LC3 II^b	1	1.51±0.01	2.51±0.02	2.57±0.01	1.22±0.01^**	1.69±0.01^**	1.28±0.04^**
P62 ^b	1	0.48±0.01	0.54±0.01	0.33±0.01	0.94±0.01^**	0.66±0.01^**	0.93±0.02^**

[1]	Quan Li, Yun Qu, Jinfang Xue, Hai Kang, Chuanzhu Lyu. Exploring lipid-modifying therapies for sepsis through the modulation of circulating inflammatory cytokines: a Mendelian randomization study [J]. World Journal of Emergency Medicine, 2025, 16(3): 256-261.
[2]	Peili Chen, Yan Ge, Huiqiu Sheng, Wenwu Sun, Jiahui Wang, Li Ma, Enqiang Mao. The role of early changes in routine coagulation tests in predicting the occurrence and prognosis of sepsis [J]. World Journal of Emergency Medicine, 2025, 16(2): 136-143.
[3]	Chunxue Wang, Dianyin Yang, Yuxin Zhu, Qian Yang, Tong Liu, Xiandong Liu, Dongyang Zhao, Xiaowei Bao, Tiancao Dong, Li Shao, Lunxian Tang. Circulating circular RNAs act as potential novel biomarkers for sepsis secondary to pneumonia: a prospective cohort study [J]. World Journal of Emergency Medicine, 2025, 16(2): 144-152.
[4]	Azzah S Alharbi, Raghad Hassan Sanyi, Esam I Azhar. Bacteria and host: what does this mean for sepsis bottleneck? [J]. World Journal of Emergency Medicine, 2025, 16(1): 10-17.
[5]	Chao Gong, Shengyong Xu, Youlong Pan, Shigong Guo, Joseph Harold Walline, Xue Wang, Xin Lu, Shiyuan Yu, Mubing Qin, Huadong Zhu, Yanxia Gao, Yi Li. Effects of probiotic treatment on the prognosis of patients with sepsis: a systematic review [J]. World Journal of Emergency Medicine, 2025, 16(1): 18-27.
[6]	Jingyuan Xie, Jiandong Gao, Mutian Yang, Ting Zhang, Yecheng Liu, Yutong Chen, Zetong Liu, Qimin Mei, Zhimao Li, Huadong Zhu, Ji Wu. Prediction of sepsis within 24 hours at the triage stage in emergency departments using machine learning [J]. World Journal of Emergency Medicine, 2024, 15(5): 379-385.
[7]	Juexian Wei, Hengzong Mo, Yuting Zhang, Wenmin Deng, Siqing Zheng, Haifeng Mao, Yang Ji, Huilin Jiang, Yongcheng Zhu. Evolutionary trend analysis and knowledge structure mapping of endothelial dysfunction in sepsis: a bibliometrics study [J]. World Journal of Emergency Medicine, 2024, 15(5): 386-396.
[8]	Rex Pui Kin Lam, Zonglin Dai, Eric Ho Yin Lau, Carrie Yuen Ting Ip, Ho Ching Chan, Lingyun Zhao, Tat Chi Tsang, Matthew Sik Hon Tsui, Timothy Hudson Rainer. Comparing 11 early warning scores and three shock indices in early sepsis prediction in the emergency department [J]. World Journal of Emergency Medicine, 2024, 15(4): 273-282.
[9]	Huixin Zhao, Yiming Dong, Sijia Wang, Jiayuan Shen, Zhenju Song, Mingming Xue, Mian Shao. Comparison between sepsis-induced coagulopathy and sepsis-associated coagulopathy criteria in identifying sepsis-associated disseminated intravascular coagulation [J]. World Journal of Emergency Medicine, 2024, 15(3): 190-196.
[10]	A-ling Tang, Yan Li, Li-chao Sun, Xiao-yu Liu, Nan Gao, Sheng-tao Yan, Guo-qiang Zhang. Xuebijing improves intestinal microcirculation dysfunction in septic rats by regulating the VEGF-A/PI3K/Akt signaling pathway [J]. World Journal of Emergency Medicine, 2024, 15(3): 206-213.
[11]	Qing Zhao, Jinfu Ma, Jianguo Xiao, Zhe Feng, Hui Liu. Data driven analysis reveals prognostic genes and immunological targets in human sepsis-associated acute kidney injury [J]. World Journal of Emergency Medicine, 2024, 15(2): 91-97.
[12]	Weichao Ding, Wei Zhang, Juan Chen, Mengmeng Wang, Yi Ren, Jing Feng, Xiaoqin Han, Xiaohang Ji, Shinan Nie, Zhaorui Sun. Protective mechanism of quercetin in alleviating sepsis-related acute respiratory distress syndrome based on network pharmacology and in vitro experiments [J]. World Journal of Emergency Medicine, 2024, 15(2): 111-120.
[13]	Yi Shan, Yang Zhao, Chengcheng Li, Jianxin Gao, Guogeng Song, Tanshi Li. Efficacy of partial and complete resuscitative endovascular balloon occlusion of the aorta in the hemorrhagic shock model of liver injury [J]. World Journal of Emergency Medicine, 2024, 15(1): 10-15.
[14]	Wei Zhou, Maiying Fan, Xiang Li, Fang Yu, En Zhou, Xiaotong Han. Molecular mechanism of Xuebijing in treating pyogenic liver abscess complicated with sepsis [J]. World Journal of Emergency Medicine, 2024, 15(1): 35-40.
[15]	Jingyi Wang, Li Weng, Jun Xu, Bin Du. Blood gas analysis as a surrogate for microhemodynamic monitoring in sepsis [J]. World Journal of Emergency Medicine, 2023, 14(6): 421-427.